Welcome to LookChem.com Sign In|Join Free
  • or
Benzenamine, 4-(4-ethyl-1-piperazinyl)-2-fluoro- (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

500205-60-7

Post Buying Request

500205-60-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

500205-60-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 500205-60-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,0,2,0 and 5 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 500205-60:
(8*5)+(7*0)+(6*0)+(5*2)+(4*0)+(3*5)+(2*6)+(1*0)=77
77 % 10 = 7
So 500205-60-7 is a valid CAS Registry Number.

500205-60-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(4-ethylpiperazin-1-yl)-2-fluoroaniline

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:500205-60-7 SDS

500205-60-7Downstream Products

500205-60-7Relevant academic research and scientific papers

SUBSTITUTED PYRIMIDINES USEFUL AS EGFR-T790M KINASE INHIBITORS

-

, (2015/09/23)

The present invention is directed to novel pyrimidines, their derivatives, pharmaceutically acceptable salts, solvates and hydrates thereof. The compounds and compositions of the present invention have protein kinases inhibitory activities and are expecte

PYRIMIDINYL ARYL UREA DERIVATIVES BEING FGF INHIBITORS

-

Page/Page column 91, (2008/06/13)

The invention relates to heteroaryl aryl ureas of the formula (IA), wherein the radicals and symbols have the meanings as defined herein, the use of such compounds in the treatment of protein kinase dependent diseases; to pharmaceutical preparations comprising said heteroaryl aryl ureas, to processes for the manufacture of such novel compounds and to methods of treatment comprising the use of such heteroaryl aryl ureas.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 500205-60-7